Cargando…

WT1基因在急性髓系白血病微小残留病监测中的应用

OBJECTIVE: To probe the potential utility of Wilms tumor 1 (WT1) as a marker of minimal residual disease (MRD) in acute myeloid leukemia (AML) to estimate the relapse-predicting cut-off value. METHODS: Quantitative assessment of bone marrow WT1 mRNA level was preformed using real-time quantitative r...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial office of Chinese Journal of Hematology 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7348239/
https://www.ncbi.nlm.nih.gov/pubmed/28954349
http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2017.08.009